Jump to content

The twincretin, lit up and read at the receptor — what SURPASS and SURMOUNT actually clocked, no white coat required.

WEEKLY DOSES / WHY THE STEPS TAKE TIME

Tirzepatide dosage rises slowly to spare the stomach.

The FDA label gives the first dose, each later step, and the weeks your body gets to adjust.

The slow dose rise aims to limit nausea

An upset stomach commonly begins when the dose goes up. The opening FDA dose is 2.5 mg each week for 4 weeks, given as a shallow shot beneath the skin.

The next step is 5 mg, with any later rise coming every 4 weeks in 2.5 mg steps. The highest dose on the label is 15 mg.

Later, the biggest SURPASS and SURMOUNT studies used 5 mg, 10 mg, and 15 mg. The body needs about 5 days to remove half of tirzepatide, which lets one shot cover a week.

Your three choices are the belly, upper arm, and thigh. I see the waiting weeks as a safety pause, while your doctor uses your chart to set the pace.

Tirzepatide dosage rises in set steps

Here is the tirzepatide dosage plan taken from the FDA instructions [16]:

  • Starting dose: 2.5 mg each week beneath the skin for 4 weeks
  • First increase: 5 mg each week for 4 weeks
  • Later increases, if the stomach can bear them: 2.5 mg every 4 weeks
  • 7.5 mg → 10 mg → 12.5 mg → 15 mg
  • Highest later dose: 15 mg each week

Large phase 3 SURPASS and SURMOUNT studies used 5 mg, 10 mg, and 15 mg per week. That late step is meant to confirm benefit and harm in many patients.

The 20-week rise in SURMOUNT went from 2.5 mg to 5 mg, 7.5 mg, 10 mg, and 12.5 mg, then to 10 or 15 mg [4][5]. Those are study and label doses, while your doctor uses your record to choose.

A higher Tirzepatide dose brought larger changes

Higher doses brought larger changes. Across SURPASS-1 through -5, the blood sugar average and body weight fell farther as the dose rose [8][3][10][11].

In SURMOUNT-1, average weight change at 72 weeks was -15.0% at 5 mg, -19.5% at 10 mg, and -20.9% at 15 mg. Placebo, an inactive shot, brought -3.1% [4].

The direct obesity study used each person's highest bearable dose. SURMOUNT-5 compared tirzepatide at 10 or 15 mg with semaglutide, an older weekly shot, at 1.7 or 2.4 mg.

Tirzepatide brought -20.2% weight loss, compared with -13.7% for semaglutide [5]. Diarrhea, nausea, and vomiting showed up most near a dose rise, then often eased once the dose stayed level [4][14].

The body takes several days to remove half

It takes about 5 days for the body to remove half of a tirzepatide dose [1]. That slow clearing is how a single shot lasts through the week.

Albumin is a protein carried through your blood. A small fat molecule lets the medicine ride on it, so your kidneys don't clear tirzepatide too quickly.

Phase 1, an early safety study, followed 142 people in good health and people living with type 2 diabetes, and its results supported weekly timing [1]. Tirzepatide itself slows the stomach most in the early weeks, then that effect tends to fade [23].

Your body clears nearly all of the drug over about five of those half-removal spans. Together, those spans come to roughly 25 days after the last dose.

A slow stomach can matter before a procedure [22]. Tell the care team when you last received tirzepatide.

The shot goes under the skin in three areas

The studied and approved route is a shot into the fat just beneath the skin [1][16]. The label gives you three areas: thigh, belly, and upper arm.

Pens and single-dose vials are normally kept in a refrigerator, protected from light, and never frozen. Room-temperature time differs by product, so use the limit printed on your own box.

The tirzepatide injection page follows the drug from the shot area into your blood. It also explains why weeks separate dose changes.

There's no approved pill. By clinging to albumin, a protein carried through your blood, the shot stays active across the week.